Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AMP0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 205 | 209 | PF00656 | 0.666 |
CLV_C14_Caspase3-7 | 338 | 342 | PF00656 | 0.621 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.673 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.631 |
CLV_NRD_NRD_1 | 311 | 313 | PF00675 | 0.461 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.673 |
CLV_PCSK_KEX2_1 | 179 | 181 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 195 | 197 | PF00082 | 0.771 |
CLV_PCSK_KEX2_1 | 311 | 313 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 332 | 334 | PF00082 | 0.558 |
CLV_PCSK_PC1ET2_1 | 179 | 181 | PF00082 | 0.645 |
CLV_PCSK_PC1ET2_1 | 195 | 197 | PF00082 | 0.771 |
CLV_PCSK_PC1ET2_1 | 332 | 334 | PF00082 | 0.578 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 254 | 258 | PF00082 | 0.463 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.416 |
DEG_APCC_DBOX_1 | 145 | 153 | PF00400 | 0.452 |
DOC_CKS1_1 | 344 | 349 | PF01111 | 0.530 |
DOC_CYCLIN_RxL_1 | 240 | 250 | PF00134 | 0.497 |
DOC_MAPK_gen_1 | 143 | 151 | PF00069 | 0.548 |
DOC_MAPK_gen_1 | 266 | 273 | PF00069 | 0.392 |
DOC_MAPK_gen_1 | 28 | 37 | PF00069 | 0.514 |
DOC_MAPK_MEF2A_6 | 143 | 151 | PF00069 | 0.509 |
DOC_MAPK_MEF2A_6 | 71 | 78 | PF00069 | 0.405 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.558 |
DOC_USP7_MATH_1 | 289 | 293 | PF00917 | 0.522 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.793 |
DOC_USP7_UBL2_3 | 40 | 44 | PF12436 | 0.604 |
DOC_WW_Pin1_4 | 343 | 348 | PF00397 | 0.582 |
LIG_14-3-3_CanoR_1 | 117 | 122 | PF00244 | 0.660 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.555 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.626 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.510 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.526 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.489 |
LIG_FHA_2 | 201 | 207 | PF00498 | 0.649 |
LIG_FHA_2 | 344 | 350 | PF00498 | 0.519 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.444 |
LIG_LIR_Gen_1 | 291 | 300 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 291 | 296 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 318 | 323 | PF02991 | 0.405 |
LIG_MAD2 | 33 | 41 | PF02301 | 0.474 |
LIG_NRBOX | 241 | 247 | PF00104 | 0.430 |
LIG_RPA_C_Plants | 146 | 157 | PF08784 | 0.481 |
LIG_SH2_CRK | 320 | 324 | PF00017 | 0.516 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.431 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.499 |
LIG_SH3_3 | 341 | 347 | PF00018 | 0.604 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.479 |
LIG_SH3_4 | 40 | 47 | PF00018 | 0.627 |
LIG_TYR_ITSM | 316 | 323 | PF00017 | 0.515 |
LIG_UBA3_1 | 350 | 358 | PF00899 | 0.538 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.537 |
MOD_CK1_1 | 292 | 298 | PF00069 | 0.581 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.504 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.772 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.430 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.372 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.607 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.572 |
MOD_GlcNHglycan | 333 | 336 | PF01048 | 0.431 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.733 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.482 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.481 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.581 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.624 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.619 |
MOD_LATS_1 | 50 | 56 | PF00433 | 0.600 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.345 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.615 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.460 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.575 |
MOD_PIKK_1 | 121 | 127 | PF00454 | 0.601 |
MOD_PIKK_1 | 217 | 223 | PF00454 | 0.594 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.543 |
MOD_PK_1 | 117 | 123 | PF00069 | 0.620 |
MOD_PKA_1 | 117 | 123 | PF00069 | 0.659 |
MOD_PKA_1 | 195 | 201 | PF00069 | 0.677 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.659 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.626 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.642 |
MOD_PKA_2 | 195 | 201 | PF00069 | 0.677 |
MOD_PKA_2 | 226 | 232 | PF00069 | 0.555 |
MOD_Plk_2-3 | 93 | 99 | PF00069 | 0.546 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.668 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.624 |
MOD_ProDKin_1 | 343 | 349 | PF00069 | 0.577 |
MOD_SUMO_for_1 | 276 | 279 | PF00179 | 0.477 |
MOD_SUMO_rev_2 | 250 | 256 | PF00179 | 0.503 |
TRG_DiLeu_BaEn_2 | 98 | 104 | PF01217 | 0.541 |
TRG_DiLeu_BaLyEn_6 | 298 | 303 | PF01217 | 0.531 |
TRG_ENDOCYTIC_2 | 320 | 323 | PF00928 | 0.516 |
TRG_ER_diArg_1 | 310 | 312 | PF00400 | 0.497 |
TRG_ER_diLys_1 | 357 | 360 | PF00400 | 0.508 |
TRG_Pf-PMV_PEXEL_1 | 243 | 247 | PF00026 | 0.452 |
TRG_Pf-PMV_PEXEL_1 | 301 | 305 | PF00026 | 0.478 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2N2 | Leptomonas seymouri | 61% | 77% |
A0A1X0NPB5 | Trypanosomatidae | 26% | 81% |
A0A3R7K7T1 | Trypanosoma rangeli | 31% | 89% |
A0A3S7WQL0 | Leishmania donovani | 89% | 78% |
A4H5L4 | Leishmania braziliensis | 80% | 100% |
D0A9B2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 87% |
Q4QHY6 | Leishmania major | 89% | 100% |